Paul Sakorafas
Paul Sakorafas publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #2,062,174 of 7,710,434 ranked researchers
- Rank in United States
- #623,812 of 1,627,098
- Works
- 18
- Citations
- 1.4k
- Citations per work
- 77.2
What does Paul Sakorafas research?
Paul Sakorafas's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (33%), Immunology and Microbiology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences951.0%
- Health Sciences632.7%
- Medicine632.7%
- Everything else316.3%
- 1Molecular Biology35% of their works
- 2Radiology, Nuclear Medicine and Imaging18% of their works
- 3Immunology16% of their works
- 4Hematology6% of their works
- 5Surgery4% of their works
- 6Epidemiology4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability
- RNA and protein synthesis mechanisms
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Cancer Immunotherapy and Biomarkers
Which keywords describe Paul Sakorafas's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Glycans and Biopharmaceuticals.
- TGF-ß
- PD-1 and PD-L1
- NK Cell Recognition
- Foxp3
- Protein Aggregation
- Biopharmaceuticals
- Cancer
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Glycans
- Mammalian Cells
- Recombinant Protein
- Immune Checkpoint Blockade
- Natural Killer Cells
- Ribosome
- Translation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Glycosylation183 topics
- Monoclonal Antibodies122 topics
- Therapeutic Antibodies122 topics
- Antibody Engineering91 topic
- Fc Receptors91 topic
- Cancer61 topic
- Glycans61 topic
- Biopharmaceuticals31 topic
- Mammalian Cells31 topic
- Protein Aggregation31 topic
- Recombinant Protein31 topic
- Foxp321 topic
- Immune Checkpoint Blockade21 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
- PD-1 and PD-L121 topic
- Ribosome21 topic
- TGF-ß21 topic
- Translation21 topic
Where does Paul Sakorafas work?
Paul Sakorafas's main affiliation in the publication record is Abbott (United States), United States.
How many publications and citations does Paul Sakorafas have?
OpenAlex counts 18 works and 1,389 citations for Paul Sakorafas, an h-index of 12, ranking #2,062,174 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul Sakorafas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.